Trovagene Inc (TROV) - Financial and Strategic SWOT Analysis Review
August 2019
57
About the Report
About the Report
Trovagene Inc (TROV)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Trovagene Inc (Trovagene) is a clinical-stage oncology therapeutics company that focuses on developing drugs which target cell division (mitosis) using Precision Cancer Medicine (PCM) approach for the treatment of lymphomas, leukemias and solid tumor cancers. The company lead product candidate is Onvansertib (previously known as PCM-075), a first-in-class, 3rd generation, adenosine triphosphate (ATP) competitive inhibitor of polo-like kinase 1 (PLK1) enzyme. It is being developed for treating indications such as Acute Myeloid Leukemia (AML), metastatic Castration-Resistant Prostate Cancer (mCRPC) and metastatic Colorectal Cancer (mCRC), having a KRAS mutation. Onvansertib is being evaluated in three clinical trials, namely, TROV-052, TROV-053 and TROV-054. Trovagene is headquartered in San Diego, California, the US.
Trovagene Inc Key Recent Developments
Aug 08,2019: Trovagene announces second quarter 2019 results and highlights
May 07,2019: Trovagene announces first quarter 2019 results and highlights
Mar 06,2019: Trovagene announces fourth quarter and full-year 2018 results
Nov 07,2018: Trovagene announces third quarter 2018 highlights and financial results
Aug 03,2018: Trovagene announces second quarter 2018 highlights and financial results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Trovagene Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Companies
Sysmex Inostics GmbH
Onconova Therapeutics Inc
Millennium Pharmaceuticals Inc
GlaxoSmithKline Plc
Genentech Inc
Boehringer Ingelheim International GmbH
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1-About the Company
Trovagene Inc-Key Facts
Trovagene Inc-Key Employees
Trovagene Inc-Key Employee Biographies
Trovagene Inc-Major Products and Services
Trovagene Inc-History
Trovagene Inc-Company Statement
Trovagene Inc-Locations And Subsidiaries
Head Office
Section 2-Company Analysis
Company Overview
Trovagene Inc-Business Description
Trovagene Inc-Corporate Strategy
Trovagene Inc-SWOT Analysis
SWOT Analysis-Overview
Trovagene Inc-Strengths
Trovagene Inc-Weaknesses
Trovagene Inc-Opportunities
Trovagene Inc-Threats
Trovagene Inc-Key Competitors
Section 3-Company Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Performance Chart
Financial Performance
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Section 4-Company's Lifesciences Financial Deals and Alliances
Trovagene Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Trovagene Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Trovagene Inc, Recent Deals Summary
Section 5-Company's Recent Developments
Aug 08, 2019: Trovagene announces second quarter 2019 results and highlights
May 07, 2019: Trovagene announces first quarter 2019 results and highlights
Mar 06, 2019: Trovagene announces fourth quarter and full-year 2018 results
Nov 07, 2018: Trovagene announces third quarter 2018 highlights and financial results
Aug 03, 2018: Trovagene announces second quarter 2018 highlights and financial results
Jul 09, 2018: Trovagene Presents Outlook for Second Half of 2018
Jun 22, 2018: Trovagene Announces Senior Management Change
May 08, 2018: Trovagene Announces First Quarter 2018 Highlights and Financial Results
Feb 26, 2018: Trovagene Announces Fourth Quarter and Full-Year 2017 Results
Jan 03, 2018: Trovagene to Present at the Biotech Showcase Annual Conference
Section 6-Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Trovagene Inc, Performance Chart (2014-2018)
Trovagene Inc, Ratio Charts
Trovagene Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Trovagene Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019
List of Table
List of Tables
Trovagene Inc, Key Facts
Trovagene Inc, Key Employees
Trovagene Inc, Key Employee Biographies
Trovagene Inc, Major Products and Services
Trovagene Inc, History
Trovagene Inc, Key Competitors
Trovagene Inc, Ratios based on current share price
Trovagene Inc, Annual Ratios
Trovagene Inc, Annual Ratios (Cont...1)
Trovagene Inc, Interim Ratios
Trovagene Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Trovagene Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Trovagene Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.